Pier 88 Investment Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,824
Closed -$765K 118
2020
Q4
$765K Sell
3,824
-1,830
-32% -$372K 0.25% 85
2020
Q3
$1.24M Sell
5,654
-3,662
-39% -$775K 0.38% 56
2020
Q2
$1.78M Buy
9,316
+1,096
+13% +$192K 0.51% 50
2020
Q1
$1.27M Buy
8,220
+4,520
+122% +$526K 0.47% 42
2019
Q4
$310K Buy
3,700
+1,000
+37% +$76.1K 0.12% 75
2019
Q3
$183K Sell
2,700
-12,225
-82% -$805K 0.07% 81
2019
Q2
$991K Buy
14,925
+9,635
+182% +$562K 0.42% 42
2019
Q1
$294K Buy
5,290
+1,945
+58% +$119K 0.14% 77
2018
Q4
$166K Buy
3,345
+310
+10% +$19K 0.08% 79
2018
Q3
$262K Sell
3,035
-425
-12% -$30.3K 0.11% 75
2018
Q2
$201K Buy
+3,460
New +$169K 0.09% 77

Other funds holding TDOC

Pier 88 Investment Partners's TDOC Position: Q1 2021 in Review

Pier 88 Investment Partners sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 3,824 shares — an estimated $765K sold.

Pier 88 Investment Partners first reported a position in TDOC in Q2 2018 and held it in 11 quarters. The position peaked at $1.78M in Q2 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Pier 88 Investment Partners reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Pier 88 Investment Partners sold 3,824 Teladoc Health shares in Q1 2021, an estimated $765K.
  • Pier 88 Investment Partners first reported a position in Teladoc Health in Q2 2018 and held it in 11 quarters.
  • Pier 88 Investment Partners's Teladoc Health position peaked at $1.78M in Q2 2020.
  • 890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Pier 88 Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.